All News
'Armored' CAR T Cells Highly Active in Lymphoma After Prior CAR-T Failure
(MedPage Today) -- A next-generation, anti-CD19 enhanced (or "armored") CAR T-cell product showed promising efficacy and safety in a phase I trial of lymphoma patients who had previously failed anti-
Read MoreTrump Has Called for More Babies but Dismissed Fertility Experts
The research team studying how to improve I.V.F. was a casualty of cutbacks at federal health agencies.
Read MoreWhite House Yanks Pick for Surgeon General
(MedPage Today) -- The White House is withdrawing the nomination of a former Fox News medical contributor Janette Nesheiwat, MD, for U.S.
Read MoreRFK Jr. Unveils Autism Patient Database Project
(MedPage Today) -- The NIH and the Centers for Medicare & Medicaid Services (CMS) will build a data platform to conduct research across claims data, electronic health record (EHR) data, and consu
Read MoreBCG Revaccination Hopes Dim for Tuberculosis Prevention
(MedPage Today) -- Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a phase IIb t
Read MoreWhite House withdraws nomination of a former Fox News contributor for U.S. surgeon general
The White House is withdrawing the nomination of former Fox News medical contributor Janette Nesheiwat for U.S. surgeon general.
Read MoreSTAT+: Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes drugs from compounding pharmacies.
Read MoreFrancis Collins blasts Trump administration’s ‘slash-and-burn’ actions at science agencies
Francis Collins: The Trump administration is “basically taking ‘move fast and break things’ and applying it to our nation’s medical research enterprise.
Read MoreHouse GOP Backs Off Some Medicaid Cuts as Report Says Millions Would Lose Healthcare
(MedPage Today) -- House Republicans appear to be backing off some, but not all, of the steep reductions to the Medicaid program as part of their big tax breaks bill, as they run into resistance from
Read MoreAfatinib Improved PFS in Lung Cancer With Uncommon Mutations
(MedPage Today) -- Patients with advanced non-small cell lung cancer and uncommon EGFR mutations lived almost twice as long without disease progression with the targeted agent afatinib (Gilotrif) ver
Read More